ProBioGen AG
Tanja Arnouk is currently the Head of Viral Vector Processing Development & Production at ProBioGen AG since July 2022. Previously, Tanja worked as a Scientist at Boehringer Ingelheim from April 2019 to July 2022. Tanja also served as a Phd Candidate at Otto-von-Guericke-University Magdeburg from November 2015 to July 2019. With a Master of Science in Biopharmazeutische Technologie and a Diplom in Biotechnology, their expertise in the field is well-established. Tanja has also gained experience as a Project Manager at ehc-memtec and as a trainee at Experimental Ophtalmology at the Johannes Gutenberg University Mainz.
This person is not in any offices
ProBioGen AG
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.